Metrics in Balance N.V. (EPA:MLMIB)
France · Delayed Price · Currency is EUR 0.0330
0.00 (0.00%)
At close: Oct 23, 2026
Metrics in Balance Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
144.89K
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 30.10K | 29.80K | 9,933.33% |
| Dec 31, 2023 | 300.00 | - | - |
| Dec 31, 2022 | 300.00 | -54.72K | -99.45% |
| Dec 31, 2021 | 55.02K | 13.73K | 33.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 48.92B |
| EssilorLuxottica Société anonyme | 29.29B |
| Eurofins Scientific SE | 7.39B |
| Sartorius Stedim Biotech | 3.01B |
| Spineway | 12.96M |
| Bluelinea Société Anonyme | 9.60M |
| Safe Orthopaedics | 5.36M |
| IntegraGen | 5.02M |